Overview

Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical efficacy and safety of ISV-502 compared to AzaSiteĀ® alone, Dexamethasone alone, and vehicle in the treatment of subjects with Non-bacterial Blepharitis.
Phase:
Phase 3
Details
Lead Sponsor:
InSite Vision
Sun Pharma Global FZE
Treatments:
Azithromycin
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate